Home›Companies›General Proximity
General Proximity

The next generation of induced-proximity medicines.

Active Founders
Armand completed his PhD in Chemical Biology at the Scripps Research Institute under the supervision of Dr. Benjamin F. Cravatt. There he co-authored 19 scientific publications in prestigious journals such as Cell, Nature, and Science, as well as multiple patents, including a portion of the foundational IP for Abide Therapeutics (acq. Lundbeck) and Vividion Therapeutics (acq. Bayer). Prior to founding GP he was an early employee at the Flagship Pioneering start-up Inzen Tx (now Sonata).
General Proximity
Batch:Winter 2020
Team Size:15
Status:
Active
Location:San Francisco
Primary Partner:Jared Friedman